Clinicopathological Characteristics and Prognosis of HER2-Low Early-Stage Breast Cancer: A Single-Institution Experience.

Front Oncol · 2022 · PMC9245921 · PMID 35785207

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although it did not reach statistical significance, Horisawa et al. found that HER2-low patients ( n = 3,169) tended to have a better prognosis than those in the HER2-zero group ( n = 838) regardless of HR status, and it seemed that the better prognosis of the HER2-low population became increasingly apparent as time went on ( 16 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.